ARCHIVES

New Data Support Claims That Costs Are Higher For Protocol Patients

This article is from The Cancer Letter archive.

Vol. 10 No. 33 | August 31, 1984

Download PDF Visit The Full Archive

Related Articles

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo”

March 20, 1981

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011